Skip to content

ROCHESTER MEDICAL CORPORATION: 10-K filed 2011-12-09

What ROCHESTER MEDICAL CORPORATION reported in its annual report filed 2011-12-09 (fiscal FY 2011): 45 published measures, 120 facts as tagged in accession 0001193125-11-336264.

This filing

Form
10-K (annual report)
Filed
2011-12-09
Fiscal period
fiscal FY 2011
Accession
0001193125-11-336264 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All ROCHESTER MEDICAL CORPORATION filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2011-09-3091,139,464USD
At 2010-09-3075,666,291USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2011-09-3065,976,847USD
At 2010-09-3068,893,451USD
At 2009-09-3068,819,897USD
At 2008-09-3067,698,529USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2011-09-308,722,935USD
At 2010-09-304,545,907USD
At 2009-09-306,365,584USD
At 2008-09-308,508,000USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2010-10-01 to 2011-09-30-1,315,304USD365
2009-10-01 to 2010-09-30-253,535USD365
2008-10-01 to 2009-09-30108,672USD365

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2010-10-01 to 2011-09-302,645,108USD365
2009-10-01 to 2010-09-303,117,622USD365
2008-10-01 to 2009-09-301,684,276USD365

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2010-10-01 to 2011-09-301,756,285USD365
2009-10-01 to 2010-09-301,763,869USD365
2008-10-01 to 2009-09-301,171,788USD365

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2010-10-01 to 2011-09-3013,353,998USD365
2009-10-01 to 2010-09-30-2,286,542USD365
2008-10-01 to 2009-09-30-653,153USD365

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2010-10-01 to 2011-09-30-11,728,999USD365
2009-10-01 to 2010-09-30-2,768,333USD365
2008-10-01 to 2009-09-30-2,735,080USD365

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2011-09-3013,263,374USD
At 2010-09-3014,578,678USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2010-10-01 to 2011-09-3012,217,900shares365
2009-10-01 to 2010-09-3012,181,549shares365
2008-10-01 to 2009-09-3012,045,313shares365

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2010-10-01 to 2011-09-3012,217,900shares365
2009-10-01 to 2010-09-3012,181,549shares365
2008-10-01 to 2009-09-3012,639,853shares365

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2010-10-01 to 2011-09-30-0.11USD/shares365
2009-10-01 to 2010-09-30-0.02USD/shares365
2008-10-01 to 2009-09-300.01USD/shares365

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2010-10-01 to 2011-09-30-0.11USD/shares365
2009-10-01 to 2010-09-30-0.02USD/shares365
2008-10-01 to 2009-09-300.01USD/shares365

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2010-10-01 to 2011-09-30-623,162USD365
2009-10-01 to 2010-09-30523,864USD365
2008-10-01 to 2009-09-30365,742USD365

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2011-09-3012,052,685USD
At 2010-09-3010,017,239USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2010-10-01 to 2011-09-301,495,773USD365
2009-10-01 to 2010-09-301,481,102USD365
2008-10-01 to 2009-09-301,330,220USD365

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2010-10-01 to 2011-09-30-1,677,416USD365
2009-10-01 to 2010-09-30208,559USD365
2008-10-01 to 2009-09-30-749,882USD365

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2011-09-3057,808,023USD
At 2010-09-3054,331,493USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2010-10-01 to 2011-09-30277,008USD365
2009-10-01 to 2010-09-30177,401USD365
2008-10-01 to 2009-09-30259,341USD365

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2011-09-3023,596,853USD
At 2010-09-306,726,513USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2011-09-302,773,398USD
At 2010-09-302,016,058USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

PeriodValueUnitDays
At 2011-09-309,764,075USD
At 2010-09-304,561,781USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2011-09-3010,061,655USD
At 2010-09-305,351,620USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2011-09-308,644,332USD
At 2010-09-307,858,540USD

Common-stock repurchase payments

Cash paid to reacquire common stock during the period. This is not an authorization limit or a direct measure of the net change in share count.

PeriodValueUnitDays
2010-10-01 to 2011-09-302,513,871USD365
2009-10-01 to 2010-09-301,202,339USD365
2008-10-01 to 2009-09-301,058,041USD365

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2010-10-01 to 2011-09-3027,774,864USD365
2009-10-01 to 2010-09-3019,495,107USD365
2008-10-01 to 2009-09-3017,575,397USD365

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2011-09-3011,278,694USD
At 2010-09-309,240,291USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2010-10-01 to 2011-09-3026,097,448USD365
2009-10-01 to 2010-09-3019,703,666USD365
2008-10-01 to 2009-09-3016,825,515USD365

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2010-10-01 to 2011-09-301,008,767USD365
2009-10-01 to 2010-09-301,235,367USD365
2008-10-01 to 2009-09-301,241,095USD365

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2011-09-3012,141,817shares
At 2010-09-3012,072,452shares

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2011-09-30-4,115,877USD
At 2010-09-30-2,885,758USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2011-09-3030,102,729USD
At 2010-09-3026,541,236USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2011-09-3018,050,044USD
At 2010-09-3016,523,997USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2011-09-301,500,544USD
At 2010-09-30610,570USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2011-09-301,361,259USD
At 2010-09-30846,899USD

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2010-10-01 to 2011-09-30-2,545,423USD365
2009-10-01 to 2010-09-30-286,121USD365
2008-10-01 to 2009-09-30-1,495,819USD365

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2010-10-01 to 2011-09-307,799,210USD365
2009-10-01 to 2010-09-306,391,003USD365
2008-10-01 to 2009-09-306,006,906USD365

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2010-10-01 to 2011-09-301,538,102USD365
2009-10-01 to 2010-09-301,407,963USD365
2008-10-01 to 2009-09-301,234,081USD365

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2010-10-01 to 2011-09-30-123,901USD365
2008-10-01 to 2009-09-301,200,442USD365

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2010-10-01 to 2011-09-30-261,050USD365
2009-10-01 to 2010-09-3061,770USD365
2008-10-01 to 2009-09-301,224,296USD365

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

PeriodValueUnitDays
2010-10-01 to 2011-09-30-834,412USD365
2009-10-01 to 2010-09-30-172,627USD365
2008-10-01 to 2009-09-30196,545USD365

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2010-10-01 to 2011-09-30646,917USD365
2009-10-01 to 2010-09-3040,942USD365
2008-10-01 to 2009-09-301,782,700USD365

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2010-10-01 to 2011-09-30-652,640USD365
2009-10-01 to 2010-09-301,481,287USD365
2008-10-01 to 2009-09-30657,793USD365

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2010-10-01 to 2011-09-30323,136USD365
2009-10-01 to 2010-09-30-409,967USD365
2008-10-01 to 2009-09-301,101,735USD365

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2010-10-01 to 2011-09-30478,189USD365
2009-10-01 to 2010-09-30269,679USD365
2008-10-01 to 2009-09-30-320,632USD365

Inspect the source

Entity
ROCHESTER MEDICAL CORPORATION / CIK 0000868368
Captured
SEC response SHA-256
362e84110d61e12107b2cc1736ab51c9a476834b83d5df8d84105658c207df9f

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000868368.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))